"Pharma Bro" Martin Shkreli is either a con man who scammed hedge fund investors of millions or a nerdy genius who made them even richer.

Several potential jurors at the federal securities fraud trial of Martin "Pharma Bro" Shkreli were excused on Monday after telling the judge they couldn't be impartial toward him.

A pharmaceutical executive who came under fire for jacking up the price of a lifesaving malaria medication has pleaded not guilty to new charges in his securities fraud case.

The strategy takes advantage of a simple fact: If generic drugmakers can't get their hands on the original product, they cannot perform the tests needed to develop a generic version.

The drug company CEO who sparked worldwide outrage for raising the price of a life-saving pill by 5,000 per cent has been arrested on securities fraud.

After weeks of criticism for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

Stepping into the uproar over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was jacked up to $750 per pill by Turing Pharmaceuticals.

Meet Valeant Pharmaceuticals, the Laval, Que.-based owner of several medications that have experienced a rapid acceleration in costs in recent years.

What would you do if a drug you needed to stay alive went from $13.50 a pill to $750 overnight? That happened to many people with life-threatening illnesses recently when the price of a 62-year-old medication increased more than 5,000 per cent.